Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Earnings (PER)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Earnings (PER) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PER(x) 48.11----

What is the latest Price to Earnings (PER) ratio of MANKIND PHARMA ?

The latest Price to Earnings (PER) ratio of MANKIND PHARMA is 48.11 based on Mar2024 Consolidated results.
Year Price to Earnings (PER)
Mar202448.11
Mar2023-
Mar2022-
Mar2021-
Mar2020-

How is Price to Earnings (PER) of MANKIND PHARMA Trending?

Years Price to Earnings (PER) % Change
Mar2024 48.11
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0
0
Mar2020 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Earnings (PER) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,173.1 Cr -1.4% 4.5% 4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,706.0 Cr 2.3% 11.7% 5.1% Stock Analytics
DIVIS LABORATORIES ₹152,946.0 Cr -1.6% 4% 58.7% Stock Analytics
CIPLA ₹120,751.0 Cr 0.8% 6.2% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,988.0 Cr 0.7% 9.8% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,066.7 Cr -1% 2.8% -8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.4%

4.5%

4.7%

SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses